Researchers compared medications taken by more than 50,000 women over the age of 50, using de-identified medical records from 2004–2013, to analyze differences in those with ovarian cancer and those without. Women who used nitrogen-based bisphosphonates were found to be less likely to develop ovarian cancer, says Karen Tuesley, a PhD candidate at the University of Queensland...